Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248283 · ClinicalTrials.gov registry record · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
A NA study of Urinary Incontinence and Urinary Incontinence,Stress, sponsored by Uromedica.
- Recruiting
- Registry status
- NA
- Development phase
- 167
- Enrollment target
- 2
- Study locations
NCT04248283: Recruiting NA study of Urinary Incontinence and Urinary Incontinence,Stress, sponsored by Uromedica.
NCT04248283 is a NA study of Urinary Incontinence and Urinary Incontinence,Stress that is actively recruiting participants, run by Uromedica. The registered enrollment target is 167 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (36% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248283, a NA study of Urinary Incontinence and Urinary Incontinence,Stress, is actively recruiting participants, sponsored by Uromedica.
- RECRUITING
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
Primary Outcome
Change in provocative pad weight from baseline
Conditions Studied
Interventions
- DEVICE Adjustable Continence Therapy for Women (ACT)
Study Locations (2)
Colorado
- University of Colorado - Denver
Nebraska
- CHI Health Research Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2021-01-26 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT04248283 shows while recruiting
NCT04248283 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (36% lower).
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Adjustable Continence Therapy for Women (ACT) is the first listed.
NCT04248283 reports a single indexed study location in Colorado, Nebraska.
Frequently Asked Questions
What is clinical trial NCT04248283 about?
NCT04248283 is a clinical study titled "Adjustable Continence Therapy (ACT) for the Treatment of Female SUI". A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
What is the current status of trial NCT04248283?
This trial is currently recruiting. It is a NA study. The enrollment target is 167 participants. The study started on 2021-01-26. Estimated completion is 2025-12-30.
What conditions does trial NCT04248283 study?
This clinical trial studies the following conditions: Urinary Incontinence, Urinary Incontinence,Stress.
What interventions are being tested in trial NCT04248283?
The interventions under investigation include: Adjustable Continence Therapy for Women (ACT) (DEVICE).
Who is sponsoring clinical trial NCT04248283?
This trial is sponsored by Uromedica, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04248283 being conducted?
This trial has 2 study locations across Colorado, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04248283's enrollment target sits among peer trials
167 17th of 48 higher than 32 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI